Most importantly, in the patients with obesity and T2D, we observed significantly reduced Reg3α expression, together with evidence of attenuated intestinal AMPK T172 phosphorylation suggestive of its activity (Fig. 3i, j). Here, REG3A is linked to obesity due to melanocortin 4 receptor deficiency.